WallStreetZenWallStreetZen

NYSE: RVTY
Revvity Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Revvity earnings were $237.6M for the trailing 12 months ending Jul 5, 2026, with -11.4% growth year over year. The latest RVTY earnings report on Jul 5, 2026 announced Q3 2026 earnings of $51.8M, up 27.3% from last quarter. For the last reported fiscal year 2025 ending Dec 28, 2025, RVTY reported annual earnings of $241.2M, with -10.8% growth. The next RVTY earnings date is Oct 26, 2026.

RVTY past earnings growth

How has RVTY's earnings growth performed historically?

Company
-11.44%
Industry
9.03%
Market
92.51%
RVTY's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
RVTY's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
RVTY's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

RVTY earnings history

Current Revenue
$2.9B
Current Earnings
$237.6M
Current Profit Margin
8.2%
RVTY's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

RVTY Return on Equity

Current Company
3.3%
Current Industry
-27.9%
Current Market
33%
RVTY's Return on Equity (3.3%)... subscribe to Premium to read more.
High Return on Equity Performance

RVTY Return on Assets

Current Company
2%
Current Industry
6.1%
RVTY is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when RVTY announces earnings.

RVTY Return on Capital Employed

Current Company
3.33%
Current Industry
12.3%
RVTY's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

RVTY vs Diagnostic & Research Stocks

TickerEBITDAEarningsY/Y EarningsEPS
RVTY$771.27M$237.55M-27.69%$2.09
CRL$218.31M-$238.46MN/A-$4.79
ICLR$984.64M$328.88M-9.07%$4.29
MEDP$637.17M$491.50M+28.75%$17.37
QGEN$703.39M$409.32M-2.43%$1.93
View Top Diagnostic & Research Stocks

RVTY earnings dates

Next earnings date
Oct 26, 2026

Revvity Earnings Reports & History FAQ

What were Revvity's earnings last quarter?

On RVTY's earnings call on Aug 4, 2026, Revvity (NYSE: RVTY) reported Q2 2026 earnings per share (EPS) of $0.47, up 2.17% year over year. Total RVTY earnings for the quarter were $51.82 million. In the same quarter last year, Revvity's earnings per share (EPS) was $0.46.

If you're new to stock investing, here's how to buy Revvity stock.

When does Revvity report earnings?

The next RVTY earnings date is Oct 26, 2026. Add RVTY to your watchlist to be reminded of Revvity's next earnings date.

Is Revvity profitable or losing money?

As of the last Revvity earnings report, Revvity is currently profitable. Revvity's net profit (also called net income) for the twelve months ending Jul 5, 2026 was $237.55 million, a 16.71% decrease year over year.

What was RVTY's earnings growth in the past year?

As of Revvity's earnings date in Aug 4, 2026, Revvity's earnings has grown -11.44% year over year. This is 20.47 percentage points lower than the US Diagnostics & Research industry earnings growth rate of 9.03%. RVTY earnings in the past year totalled $237.55 million.

What are Revvity's earnings expectations?

The current EPS estimate for Revvity's earnings report in Oct 26, 2026 is $1.28.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.